Trial
NCT02418273
Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Indiana University
Collaborators
—
Condition
Osteoporosis
Intervention
denosumab
Why stopped
was not funded
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-06